Buffalo, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE INC, founded in 1956, is a mid-sized nonprofit in the Medical Research sector that reported $11.0M in total revenue in fiscal year 2023. Revenue surged 27% from the prior year, signaling strong growth momentum. Expenses of $10.5M left a modest 5% surplus.
Research in Endocrine Biochemistry and Molecular Biophysics to develop and understand the causes of diseases and potential therapies for cure.
The National Science Foundation BioXFEL Science & Technology Center watched bimolecular machines at work using X-ray lasers, to better understand how life works at the molecular levels, to understand...
The National Science Foundation BioXFEL Science & Technology Center watched bimolecular machines at work using X-ray lasers, to better understand how life works at the molecular levels, to understand how these molecular machines support life on earth to invent, discover, develop and provide new tools and training for the wider scientific community.
IMCA-CAT provided an outstanding support environment for macro-molecular crystallography by developing and operating an efficient, reliable , high-throughput facility at which both confidential and...
IMCA-CAT provided an outstanding support environment for macro-molecular crystallography by developing and operating an efficient, reliable , high-throughput facility at which both confidential and proprietary equipment can be readily and easily accommodated.
The National HTX Center aims to implement a modern internet interface for users of the High-Throughput Crystallization Screening Center to interact with the images of their crystallization screening...
The National HTX Center aims to implement a modern internet interface for users of the High-Throughput Crystallization Screening Center to interact with the images of their crystallization screening experiments. A further goal is to begin development of software to enable automatic image analysis and classification.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $11,025,702 | $8,691,259 | +0.3% |
| Expenses | $10,453,501 | $9,386,732 | +0.1% |
| Net Income | $572,201 | $-695,473 | -1.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Edward Snell | Chief Scientific Officer | 37.5 |
Officer
|
$155,919 | $42,417 | $255,344 |
| Lisa Keefe | VP | 37.5 |
Officer
|
$225,718 | $14,022 | $239,740 |
| Anne Kent | Chief Financial Officer | 37.5 |
Officer
|
$152,939 | $27,072 | $180,011 |
| Devrim Acehan | Cryo-EM Director | 37.5 |
Highest
|
$138,942 | $28,409 | $167,351 |
| Daniel Gewirth | Principal Research Scientist | 37.5 |
Highest
|
$134,964 | $23,158 | $158,122 |
| John Muir | Software Developer | 37.5 |
Highest
|
$122,732 | $30,982 | $153,714 |
| Blanca Carbajal | Business Development Director | 37.5 |
Highest
|
$136,678 | $2,776 | $139,454 |
| Aviv Paz | Principal Investigator | 37.5 |
Highest
|
$102,505 | $29,194 | $131,699 |
| Sarah Bowman | Board Member/Associate Investigator | 37.5 |
Director
|
$99,753 | $23,412 | $123,165 |
| Christopher Greene | Interim CEO | 1 |
Officer
Director
|
$120,000 | $0 | $120,000 |
| Christina Arthurs | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| LaVonne Ansari | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Tricia Barrett | Board Member/Vice Chairperson of the Board | 0.2 |
Officer
Director
|
$0 | $0 | $0 |
| Steve Bell | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Jill Bond | Board Member/Secretary | 0.2 |
Officer
Director
|
$0 | $0 | $0 |
| EJ Burke | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| William Constantine | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Artem Evdokimov | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Frank Ewing | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Venu Govindaraju | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Andrei Gudkov | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| William Harries | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Michele Heffernan | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Dan Magnuszewski | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Brenda McDuffie | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Sean Moskal | Chairman of Finance Committee | 0.2 |
Officer
Director
|
$0 | $0 | $0 |
| Philip Nobel | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Jeffrey Renzoni | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Nena Rich | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Sam Russo | Board Member/Chairperson of the Board | 0.2 |
Officer
Director
|
$0 | $0 | $0 |
| Franca Trincia | Board Member | 0.2 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $11,025,702 | $10,453,501 | $27,556,503 | $572,201 |
| 2023 | $8,691,259 | $9,386,732 | $26,875,141 | $-695,473 |
| 2022 | $6,895,666 | $7,228,048 | $23,417,551 | $-332,382 |
| 2021 | $9,359,091 | $6,944,091 | $26,101,769 | $2,415,000 |
| 2020 | $6,939,060 | $7,407,374 | $22,935,072 | $-468,314 |
| 2019 | $5,204,564 | $7,227,288 | $22,455,303 | $-2,022,724 |
| 2018 | $8,037,897 | $7,462,126 | $22,430,958 | $575,771 |
Compare HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE INC with other nonprofits in New York and across the country.